This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Research

Cognitive Change in the Year After a First Manic Episode: Association Between Clinical Outcome and Cognitive Performance Early in the Course of Bipolar I Disorder

Jan-Marie Kozicky, PhD; Ivan J. Torres, PhD; Leonardo E. Silveira, MD, PhD; David J. Bond, MD, PhD; Raymond W. Lam, MD; and Lakshmi N. Yatham, MD, MBBS

Published: June 27, 2014

Article Abstract

Objective: Cognitive impairments are present immediately following recovery from a first episode of mania, although at a lesser severity than those seen in more chronic patients with bipolar I disorder. Little is known about how deficits evolve over the course of illness, however, and whether these changes are associated with disease progression.

Method: Patients with bipolar I disorder (DSM-IV-TR) receiving naturalistic clinical follow-up from the Systematic Treatment Optimization Program for Early Mania (STOP-EM) from July 2004 to May 2013 completed a comprehensive cognitive battery following recovery from their first manic episode and again 1 year later. Performance was compared between patients who experienced a recurrence of a mood episode (BDrecur) (n = 26) versus those that maintained remission (BDwell) (n = 27) over follow-up, as well as healthy comparison subjects (HS) (n = 31).

Results: While both BDrecur and BDwell had impairments in overall cognitive performance relative to HS at baseline (mean difference = −0.59, P < .001; mean difference = −0.43, P < .05, respectively), at follow-up BDrecur showed deficits compared to both HS (mean difference = −0.62, P = .001) and BDwell (mean difference = −0.41, P = .05), with BDwell cognition similar to that in HS (mean difference = −0.21, P > .4). BDwell showed larger improvements over follow-up relative to both other groups (P < .05). While changes in BDrecur did not differ from HS, in this group more days in a manic or hypomanic episode was associated with performance declines (r = -0.40, P < .05).

Conclusions: While cognitive function improves in patients who sustain remission in the year following a first manic episode, those who experience a recurrence remain impaired, with performance declines being most apparent in those who experienced longer manic or hypomanic episodes.

Volume: 75

Quick Links: Bipolar Disorder

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...